American predictive toxicology company at Research Triangle Park in North Carolina, formed in 2015 out of the computational and systems biology work of the Hamner Institutes. Combines in vitro assays with computational modelling to predict human chemical and drug safety, offering high throughput screening, physiologically based pharmacokinetic modelling, in vitro to in vivo extrapolation and new approach methodologies for pharmaceutical, chemical and consumer product clients and for regulatory programmes.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen